Target intelligence / Profile preview

Secale cereale allergens

Molecular classification
Pollen allergens, Seed storage proteins (prolamins/secalins), Group 5 grass pollen allergens, Beta-expansin
01

Overview

Secale cereale allergens are proteins from rye (Secale cereale) pollen and grain that trigger IgE-mediated allergic reactions, primarily in respiratory and food allergy contexts. Key pollen allergens include those at 28 kDa, 33 kDa, 48 kDa, and 67 kDa, with Sec c 5 (group 5 grass pollen allergen) and Sec c 4 identified specifically; grain allergens feature secalins like Sec c 38 (γ-secalin) and Sec c 20, which are prolamins resistant to digestion. These allergens cause conditions such as allergic rhinitis from pollen inhalation, baker's asthma from flour exposure, and food allergies including anaphylaxis, often via cross-reactivity with wheat gliadins, barley hordeins, and grass pollens. No therapeutic drugs target these allergens for modulation; instead, pollen extracts are used solely for diagnostic allergy testing via skin prick or intradermal routes. Processing like fermentation may reduce but not eliminate allergenicity due to protein stability. Overall, they represent environmental and occupational allergens rather than druggable therapeutic targets.

Other names
Rye allergensCultivated rye allergens (g12)Rye grain allergens (f5)Sec c 1 (renamed Sec c 38)Sec c 4Sec c 5Sec c 20Sec c 38γ-secalin
02

Mechanism of action

Diagnostic allergen for skin prick testing and IgE detection (no therapeutic drugs target for modulation)

03

Biological functions

Allergenicity (IgE-mediated immune response)Pollen release and structural components
04

Disease associations

Allergic rhinitisBaker's asthmaFood allergyWheat-dependent exercise-induced anaphylaxisAnaphylaxis
05

Safety considerations

Risk of anaphylaxis in sensitized individuals during exposure or testingCross-reactivity with wheat, barley, grass pollens increasing misdiagnosis or reaction risk
06

Interacting drugs

Secale cereale pollen extract (allergy testing extracts)
07

Biomarkers

Serum IgE to Sec c 38, Sec c 20, Sec c 5 for rye allergy diagnosis

Beyond the preview

Go deeper on Secale cereale allergens.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Secale cereale allergens.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call